Research Progress in Tumor Therapy Targeting Plasminogen Activator Inhibitor-1
Author:
Affiliation:

1.State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, China;2.University of Chinese Academy of Sciences, Beijing 100049, China;3.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China;4.College of Chemistry, Fuzhou University, Fuzhou 350116, China

Clc Number:

Fund Project:

This work was supported by grants from National Key R&D Program of China (2017YFE0103200), The National Natural Science Foudation of China (31370737, 81572944), the CAS/SAFEA International Partnership Program for Creative Research Teams, the High-Level Entrepreneurship and Innovation Talents Projects in Fujian Province ([2018]8-1).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Cancer is a serious disease that endangers human health. Solid tumors are surrounded by extracellular matrix, infiltrated immune cells, and the secretum of surrounding mesenchymal cells. The tumor microenvironment plays a key role in tumorigenesis, tumor growth, and resistance to antineoplastic therapy. Plasminogen activator inhibitor-1 (PAI-1) is an important regulatory factor in tumor microenvironment. PAI-1 not only functions as a key constitution with tissue-type plasminogen activators (tPA) in regulating fibrinolytic activity, but also participates in invasion, infiltration and migration of tumor. In this paper, the structure and function of PAI-1 and its significance in tumor microenvironment in recent years are reviewed. It is considered that PAI-1 may be an important target for anti-cancer therapy. At the same time, the latest research results of PAI-1 inhibitors in the field of anticancer were analyzed, and the potential application value of PAI-1 inhibitors was demonstrated.

    Reference
    Related
    Cited by
Get Citation

LIU Ji-Hao, TANG Shu-Zhi, HU Li-Hong, HUANG Ming-Dong, CHEN Zhuo. Research Progress in Tumor Therapy Targeting Plasminogen Activator Inhibitor-1[J]. Progress in Biochemistry and Biophysics,2019,46(7):663-672

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 17,2019
  • Revised:May 21,2019
  • Accepted:May 24,2019
  • Online: September 25,2019
  • Published: July 20,2019